Aptose Biosciences Inc. (APTOF) › Net IncomeAptose Biosciences Inc. (APTOF) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$11.64M2018: -$28.87M2019: -$26.28M2020: -$55.24M2021: -$65.35M2022: -$41.82M2023: -$51.21M2024: -$25.43M2025: -$25.47M-$25.47M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$25.47M-0.1%2024-$25.43M+50.3%2023-$51.21M-22.4%2022-$41.82M+36.0%2021-$65.35M-18.3%2020-$55.24M-110.2%2019-$26.28M+9.0%2018-$28.87M-147.9%2017-$11.64M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share